Pediatric Blood & Cancer

Papers
(The H4-Index of Pediatric Blood & Cancer is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Glomerular filtration rate in children and young adults with haemato‐oncological disease and infection is best described by three‐compartment iohexol model69
A three‐year‐old with central nervous system graft versus host disease: A rare cause of posthematopoietic stem cell transplant encephalopathy47
Pediatric erythroblastic transformation of JAK2‐mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations41
37
Psychosexual functioning in cancer survivorship: What the pediatric oncologist needs to know36
35
Feasibility of treating pediatric intracranial germ cell tumors in a middle‐income country: The Jordanian experience33
Image‐Guided Biopsy for the Diagnosis and Molecular Profiling of Hepatoblastoma33
Lactate dehydrogenase reflects the status of ultra‐high‐risk neuroblastoma in a child under treatment32
The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis32
A randomized double‐blind placebo‐controlled trial of the effectiveness of melatonin on neurocognition and sleep in survivors of childhood cancer31
Mini‐hyper CVD + CRIB (condensed rituximab, inotuzumab ozogamicin, and blinatumomab) for refractory pediatric B‐acute lymphoblastic leukemia31
Refractory thrombocytopenia and myelofibrosis in a novel KDSR mutation: Case report and literature review29
Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy28
Bone mineral density in primarily preadolescent children with hemoglobin E/β‐thalassemia with different severities and transfusion requirements27
Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort25
Recombinant von Willebrand factor for perioperative bleeding management in pediatric patient with allergy to plasma‐derived von Willebrand factor25
Choriocarcinoma in neonates and infants: A severe but curable disease25
Neonatal giant axillary hemangioma with subclavian arteriovenous fistula and heart failure25
Social determinants of neurocognitive and academic performance in sickle cell disease24
Brochure intervention to manage bothersome taste changes in pediatric patients receiving cancer therapy24
ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant24
Platelet changes and bleeding symptoms in children, adolescents, and adults with 22q11.2 deletion syndrome23
Prognostic factors of sepsis in children with acute leukemia admitted to the pediatric intensive care unit23
0.22667407989502